Morepen Bio Inc

2 FDA products 2 active ingredients HUMAN OTC DRUG

Morepen Bio Inc is listed as the manufacturer on 2 FDA drug label records covering 2 distinct active ingredients predominantly human otc drug products.

About Morepen Bio Inc

Morepen Bio Inc is named as the labeler on 2 FDA drug label records. Its catalogue spans 2 distinct active ingredients, led by DOCUSATE SODIUM AND SENNOSIDES, SENNOSIDES. Most of these labels are human otc drug products. Labelling across this portfolio most often references: usage indications. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
DOCUSATE SODIUM AND SENNOSIDES 1
SENNOSIDES 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 2
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Morepen Bio Inc

Brand nameGenericTypeRoute
Docusate Sodium and Sennosides DOCUSATE SODIUM AND SENNOSIDES HUMAN OTC DRUG ORAL
Sennosides 8.6 mg SENNOSIDES HUMAN OTC DRUG ORAL

Frequently asked questions

How many FDA drug products does Morepen Bio Inc make?
2 FDA drug label records name Morepen Bio Inc as the manufacturer, covering 2 distinct active ingredients.

What active ingredients does Morepen Bio Inc produce?
The most frequent active ingredients in this portfolio are DOCUSATE SODIUM AND SENNOSIDES, SENNOSIDES.

Are Morepen Bio Inc products prescription or over-the-counter?
The largest share of this company’s labels are human otc drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.